Last ¥1,301 JPY
Change Today -41.00 / -3.06%
Volume 960.5K
4571 On Other Exchanges
Symbol
Exchange
Tokyo
Frankfurt
As of 1:00 AM 11/26/14 All times are local (Market data is delayed by at least 15 minutes).

nanocarrier co ltd (4571) Snapshot

Open
¥1,348
Previous Close
¥1,342
Day High
¥1,375
Day Low
¥1,299
52 Week High
12/6/13 - ¥2,580
52 Week Low
05/21/14 - ¥885.00
Market Cap
52.4B
Average Volume 10 Days
468.1K
EPS TTM
¥-35.56
Shares Outstanding
40.3M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for NANOCARRIER CO LTD (4571)

Related News

No related news articles were found.

nanocarrier co ltd (4571) Related Businessweek News

No Related Businessweek News Found

nanocarrier co ltd (4571) Details

NanoCarrier Co., Ltd. researches and develops various pharmaceuticals for the treatment of cancer in Japan. The company’s products include Nanoplatin for the treatment of pancreatic, solid, and non small cell lung cancer; DACH-Platin Micelle for the treatment of bowel cancer; Epirubicin Micelle; and Paclitaxel Micelle for the treatment of stomach and breast cancer. It also develops Sensor Linked Micelle, small interfering RNA Micelle, and Protein Micelle, as well as Docetaxel Micelle for the treatment of breast, non-small cell lung, uterus, ovarian, and prostatic cancer. The company was founded in 1996 and is headquartered in Kashiwa, Japan.

40 Employees
Last Reported Date: 06/26/14
Founded in 1996

nanocarrier co ltd (4571) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

nanocarrier co ltd (4571) Key Developments

NanoCarrier Co., Ltd. Announces Consolidated Earnings Results for the Six Months Ended September 30, 2014; Provides Earnings Guidance for the Fiscal Year Ending March 31, 2015

NanoCarrier Co., Ltd. announced consolidated earnings results for the six months ended September 30, 2014. For the period, the consolidated company reported net sales of ¥311 million, operating income of ¥507 million, ordinary income of ¥149 million, net income of ¥151 million or net income per share of ¥3.76 compared to net sales of ¥325 million, operating income of ¥501 million, ordinary income of ¥436 million, net income of ¥437 million or net income per share of ¥13.02 for the same period last year. Loss before income taxes was ¥149.49 million against ¥436.17 million a year ago. Net cash used in operating activities was ¥515.66 million against ¥475.84 million a year ago. Purchase of property, plant and equipment was ¥115.74 million against ¥17.8 million a year ago. Purchase of intangible assets was ¥3.22 million against ¥0.090 million a year ago. The company expected sales for the current fiscal year ending March 31, 2015 are expected to be ¥560 million, an increase of 18.6% compared to the previous fiscal year, mainly comprised of the supply revenues of the trial drug materials and cosmetics materials under the existing contracts, and other contract revenues. Operating loss and the ordinary loss are expected to be ¥1,428 million compared with the loss of ¥1,123 million for the previous fiscal year and ¥1,029 million compared with the loss of ¥1,094 million for the previous fiscal year, respectively. The net loss is expected to increase to ¥1,070 million from ¥1,113 million for the previous fiscal year. The company expected net income per share of ¥26.57 for the fiscal year ending March 31, 2015.

NanoCarrier Co., Ltd. to Report Q2, 2015 Results on Nov 11, 2014

NanoCarrier Co., Ltd. announced that they will report Q2, 2015 results on Nov 11, 2014

NanoCarrier Co., Ltd., Q2 2015 Earnings Call, Nov 13, 2014

NanoCarrier Co., Ltd., Q2 2015 Earnings Call, Nov 13, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4571:JP ¥1,301.00 JPY -41.00

4571 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 4571.
View Industry Companies
 

Industry Analysis

4571

Industry Average

Valuation 4571 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 109.4x
Price/Book 3.7x
Price/Cash Flow NM Not Meaningful
TEV/Sales 85.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NANOCARRIER CO LTD, please visit www.nanocarrier.co.jp. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.